Fig. 1From: Safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses of BI 187004, an inhibitor of 11beta-hydroxysteroid dehydrogenase-1, in healthy male volunteers with overweight or obesityArithmetic mean plasma concentration–time profile of BI 187004 after single oral administration of 2.5, 5, 10, 20, 40, 80, 160, 240 and 360 mg BI 187004 for (A) 24 h and (B) 96 h after drug administration. n = 5 (2.5 mg), n = 6 (5–360 mg)Back to article page